Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussein Sweiti

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Systematic Reviews|November 27, 2015
Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic reviewHussein Sweiti, Obinna Ekwunife, Thomas Jaschinski, et al.
Current Therapeutic Research, Clinical and Experimental|August 2, 2017
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic ReviewHussein Sweiti, Obinna Ekwunife, Thomas Jaschinski, et al.
Drug Discovery Today|June 4, 2019
Physicians in the pharmaceutical industry: their roles, motivations, and perspectivesHussein Sweiti, Frank Wiegand, Christoph Bug, et al.
Cancers|September 11, 2020
Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized TrialHenrik Suttmann, Jochen Gleissner, Andreas Huebner, et al.
Sarcoma|April 26, 2018
Limb-Salvage Surgery of Soft Tissue Sarcoma with Sciatic Nerve InvolvementHussein Sweiti, Noor Tamimi, Fabian Bormann, et al.
Surgery|January 21, 2011
Ischemic colitis: who will survive?Christoph Reissfelder, Hussein Sweiti, Dalibor Antolovic, et al.
The Oncologist|May 13, 2026
Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial programAnne O'Hagan, Arlene Siefker-Radtke, Yohann Loriot, et al.
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
BMC Cancer|August 13, 2024
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trialJoon Oh Park, Yin-Hsun Feng, Wu-Chou Su, et al.
JCO Precision Oncology|July 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary CohortsOmar Carranza, Shubham Pant, Martin Schuler, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Systematic Reviews|November 27, 2015
Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic reviewHussein Sweiti, Obinna Ekwunife, Thomas Jaschinski, et al.
Current Therapeutic Research, Clinical and Experimental|August 2, 2017
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic ReviewHussein Sweiti, Obinna Ekwunife, Thomas Jaschinski, et al.
Drug Discovery Today|June 4, 2019
Physicians in the pharmaceutical industry: their roles, motivations, and perspectivesHussein Sweiti, Frank Wiegand, Christoph Bug, et al.
Cancers|September 11, 2020
Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized TrialHenrik Suttmann, Jochen Gleissner, Andreas Huebner, et al.
Sarcoma|April 26, 2018
Limb-Salvage Surgery of Soft Tissue Sarcoma with Sciatic Nerve InvolvementHussein Sweiti, Noor Tamimi, Fabian Bormann, et al.
Surgery|January 21, 2011
Ischemic colitis: who will survive?Christoph Reissfelder, Hussein Sweiti, Dalibor Antolovic, et al.
The Oncologist|May 13, 2026
Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial programAnne O'Hagan, Arlene Siefker-Radtke, Yohann Loriot, et al.
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
BMC Cancer|August 13, 2024
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trialJoon Oh Park, Yin-Hsun Feng, Wu-Chou Su, et al.
JCO Precision Oncology|July 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary CohortsOmar Carranza, Shubham Pant, Martin Schuler, et al.
Pageof 2